Tue, August 7, 2018
Mon, August 6, 2018
Fri, August 3, 2018

Gena Wang Maintained (BMRN) at Hold with Increased Target to $98 on, Aug 6th, 2018

Gena Wang of Barclays, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Hold with Increased Target from $95 to $98 on, Aug 6th, 2018.

Gena has made no other calls on BMRN in the last 4 months.



There are 5 other peers that have a rating on BMRN. Out of the 5 peers that are also analyzing BMRN, 0 agree with Gena's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Gena


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $115 on, Friday, August 3rd, 2018
  • Stephen Willey of "Stifel" Maintained at Strong Buy with Increased Target to $109 on, Friday, August 3rd, 2018
  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $113 on, Tuesday, July 31st, 2018
  • M. Auster of "Credit Suisse" Maintained at Buy with Increased Target to $122 on, Monday, July 9th, 2018
  • Cory Kasimov of "JP Morgan" Maintained at Buy with Increased Target to $133 on, Thursday, May 31st, 2018